Eyk Henning
After three lost glyphosate-cancer trials, Bayer investors fear litigation ‘avalanche’ will further harm company’s reputation
Two influential shareholder advisory groups are split on whether investors should support Bayer AG’s management at its upcoming annual meeting, ...
